Effect of the synthetic NC-1059 peptide on diffusion of riboflavin across an intact corneal epithelium

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 6, 2012, Pages 2620-2629

  Zhang, Yuntao ^a   Sukthankar, Pinakin ^a   Tomich, John M ^a   Conrad, Gary W ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NC 1059 PEPTIDE; RIBOFLAVIN; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ABSORPTION SPECTROSCOPY; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CHICK EMBRYO; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA STROMA; DRUG DIFFUSION; EMBRYO; FLUORESCENCE SPECTROSCOPY; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL;

ANIMALS; CELL MEMBRANE PERMEABILITY; CHICK EMBRYO; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORNEAL STROMA; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIUM, CORNEAL; FLAVIN MONONUCLEOTIDE; ION CHANNELS; ION TRANSPORT; MICROSCOPY, CONFOCAL; MODELS, ANIMAL; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TIME FACTORS;

EID: 84860602158     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-9537     Document Type: Article

References (67)

1. Edrington TB, Zadnik K, Barr JT. Keratoconus. Optom Clin. 1995;4:65-73.
2. Romero-Jiménez M, Santodomingo-Rubido J, Wolffsohn JS. Keratoconus: a review. Cont Lens Anterior Eye. 2010;33:157-166.
3. Garcia-Lledo M, Feinbaum C, Alio JL. Contact lens fitting in keratoconus. Compr Ophthalmol Update. 2006;7:47-52.
4. Ertan A, Colin J. Intracorneal rings for keratoconus and keratectasia. J Cataract Refract Surg. 2007;33:1303-1314.
5. Pramanik S, Musch DC, Sutphin JE, Farjo AA. Extended long-term outcomes of penetrating keratoplasty for keratoconus. Ophthalmology. 2006;113:1633-1638.
6. Tan DT, Por YM. Current treatment options for corneal ectasia. Curr Opin Ophthalmol. 2007;18:284-289.
7. Wollensak G, Sporl E, Seiler T. Treatment of keratoconus by collagen cross linking. Ophthalmologe. 2003;100:44-49.
8. Krishna CM, Uppuluri S, Riesz P, Zigler JS Jr, Balasubramanian, D. A study of the photodynamic efficiencies of some eye lens constituents. Photochem Photobiol. 1991;54:51-58.
9. McCall AS, Kraft S, Edelhauser HF, et al. Mechanisms of corneal tissue cross-linking in response to treatment with topical riboflavin and long-wavelength ultraviolet radiation (UVA). Invest Ophthalmol Vis Sci. 2010;51:129-138.
10. Brummer G, Littlechild S, McCall S, Zhang Y, Conrad GW. The role of nonenzymatic glycation and carbonyls in collagen cross-linking for the treatment of keratoconus. Invest Oph-thalmol Vis Sci. 2011;52:6363-6369.
11. Zhang Y, Conrad AH, Conrad GW. Effects of ultraviolet-A and riboflavin on the interaction of collagen and proteoglycans during corneal cross-linking. J Biol Chem. 2011;286:13011-13022.
12. Wollensak G, Spoerl E, Wilsch M, Seiler T. Endothelial cell damage after riboflavin-ultraviolet-A treatment in the rabbit. J Cataract Refract Surg. 2003;29:1786-1790.
13. Spoerl E, Huhle M, Seiler T. Induction of cross-links in corneal tissue. Exp Eye Res. 1998;66:97-103.
14. Seiler T, Hafezi F. Corneal cross-linking-induced stromal demarcation line. Cornea. 2006;25:1057-1059.
15. Spoerl E, Huhle M, Kasper M, Seiler T. Increased rigidity of the cornea caused by intrastromal cross-linking. Der Ophthalmo-loge. 1997;94:902-906.
16. Spoerl E, Schreiber J, Hellmund K, Seiler T, Knuschke P. Studies on the stabilization of the cornea in rabbits. Ophthalmologe. 2000;97:203-206.
17. Wollensak G. Crosslinking treatment of progressive keratoco-nus: new hope. Curr Opin Ophthalmol. 2006;17:356-360.
18. Bakke EF, Stojanovic A, Chen X, Drolsum L. Penetration of riboflavin and postoperative pain in corneal collagen cross-linking: excimer laser superficial versus mechanical full-thickness epithelial removal. J Cataract Refract Surg. 2009; 35:1363-1366.
19. Pollhammer M, Cursiefen C. Bacterial keratitis early after corneal crosslinking with riboflavin and ultraviolet-A. J Cataract Refract Surg. 2009;35:588-589.
20. Sharma N, Maharana P, Singh G, Titiyal JS. Pseudomonas keratitis after collagen crosslinking for keratoconus: case report and review of literature. J Cataract Refract Surg. 2010; 36:517-520.
21. Pérez-Santonja JJ, Artola A, Javaloy J, Alió JL, Abad JL. Microbial keratitis after corneal collagen crosslinking. J Cataract Refract Surg. 2009;35:1138-1140.
22. Pinelli R. Corneal cross-linking with riboflavin: entering a new era in ophthalmology. Ophthalmology Times Europe. 2006;2: 36-38.
23. Wollensak G, Iomdina E. Biomechanical and histological changes after corneal crosslinking with and without epithelial debridement. J Cataract Refract Surg. 2009;35:540-546.
24. Snibson GR. Collagen cross-linking: a new treatment paradigm in corneal disease-a review. Clin Experiment Ophthalmol. 2010;38:141-153.
25. Chan CC, Sharma M, Wachler BS. Effect of inferior-segment Intacs with and without C3-R on keratoconus. J Cataract Refract Surg. 2007;33:75-80.
26. Hayes S, O'Brart DP, Lamdin LS, et al. Effect of complete epithelial debridement before riboflavin-ultraviolet-A corneal collagen crosslinking therapy. J Cataract Refract Surg. 2008; 34:657-661.
27. Samaras K, O'Brart DP, Doutch J, Hayes S, Marshall J, Meek KM. Effect of epithelial retention and removal on riboflavin absorption in porcine corneas. J Refract Surg. 2009;25:771-775.
28. Kissner A, Spoerl E, Jung R, Spekl K, Pillunat LE, Raiskup F. Pharmacological modification of the epithelial permeability by benzalkonium chloride in UVA/Riboflavin corneal collagen cross-linking. Curr Eye Res. 2010;35:715-721.
29. Raiskup F, Pinelli R, Spoerl E. Riboflavin osmolar modification for transepithelial corneal cross-linking. Curr Eye Res. 2012; 37:234-238.
30. Karla PK, Pal D, Quinn T, Mitra AK. Molecular evidence and functional expression of a novel drug efflux pump (ABCC2) in human corneal epithelium and rabbit cornea and its role in ocular drug efflux. Int J Pharm. 2007;336:12-21.
31. Sasaki H, Yamamura K, Mukai T, et al. Enhancement of ocular drug penetration. Crit Rev Ther Drug Carrier Syst. 1999;16: 85-146.
32. Mannermaa E, Vellonen KS, Urtti A. Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics. Adv Drug Deliv Rev. 2006;58:1136-1163.
33. Klyce SD. Electrical profiles in the corneal epithelium. J Physiol. 1972;226:407-429.
34. Klyce SD, Crosson CE. Transport processes across the rabbit corneal epithelium: a review. Curr Eye Res. 1985;4:323-331.
35. Powell DW. Barrier function of epithelia. Am J Physiol. 1981; 241:G275-G288.
36. Reichl S, Bednarz J, Müller-Goymann CC. Human corneal equivalent as cell culture model for in vitro drug permeation studies. Br J Ophthalmol. 2004;88:560-565.
37. Dey S. Corneal cell culture models: a tool to study corneal drug absorption. Expert Opin Drug Metab Toxicol. 2011;7: 529-532.
38. Toropainen E, Ranta VP, Talvitie A, Suhonen P, Urtti A. Culture model of human corneal epithelium for prediction of ocular drug absorption. Invest Ophthalmol Vis Sci. 2001;42:2942-2948.
39. Yoshida Y, Ban Y, Kinoshita S. Tight junction transmembrane protein claudin subtype expression and distribution in human corneal and conjunctival epithelium. Invest Ophthalmol Vis Sci. 2009;50:2103-2108.
40. Yi X, Wang Y, Yu FS. Corneal epithelial tight junctions and their response to lipopolysaccharide challenge. Invest Oph-thalmol Vis Sci. 2000;41:4093-4100.
41. Martin J, Malreddy P, Iwamoto T, et al. NC-1059: a channel-forming peptide that modulates drug delivery across in vitro corneal epithelium. Invest Ophthalmol Vis Sci. 2009;50:3337-3345.
42. Broughman JR, Brandt RM, Hastings C, Iwamoto T, Tomich JM, Schultz BD. Channel-forming peptide modulates transepithe-lial electrical conductance and solute permeability. Am J Physiol Cell Physiol. 2004;286:C1312-C1323.
43. Somasekharan S, Brandt R, Iwamoto T, Tomich JM, Schultz BD. Epithelial barrier modulation by a channel forming peptide. J Membr Biol. 2008;222:17-30.
44. Tomich JM, Wallace D, Henderson K, et al. Aqueous solubilization of transmembrane peptide sequences with retention of membrane insertion and function. Biophys J. 1998;74:256-267.
45. Broughman JR, Shank LP, Takeguchi W, et al. Distinct structural elements that direct solution aggregation and membrane assembly in the channel-forming peptide M2GlyR. Biochemistry. 2002;41:7350-7358.
46. Sndergaard AP, Hjortdal J, Breitenbach T, Ivarsen A. Corneal distribution of riboflavin prior to collagen cross-linking. Curr Eye Res. 2010;35:116-121.
47. Lwigale PY. Nuclear morphologies of bovine corneal cells as visualized by confocal microscopy. Cells Tissues Organs. 1999; 165:104-112.
48. Renard G, Hirsch M, Savoldelli M, Pouliquen Y. Ultrastructural study of the cornea in the chick embryo. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1978;208:1-7.
49. Hay ED, Revel JP. Fine structure of the developing avian cornea. Monogr Dev Biol. Basel, 1969;1:1-144.
50. Masterson E, Edelhauser HF, van Horn DL. The role of thyroid hormone in the development of the chick corneal endothe-lium and epithelium. Invest Ophthalmol Vis Sci. 1977;16:105-115.
51. Keating A, Pineda R II, Colby K. Corneal cross linking for keratoconus. Semin Ophthalmol. 2010;25:249-255.
52. Schneeberger EE, Lynch RD. The tight junction: a multifunctional complex. Am J Physiol Cell. 2004;286:C1213-C1228.
53. Brignole-Baudouin F, Riancho L, Liang H, Nakib Z, Baudouin C. In vitro comparative toxicology of polyquad-preserved and benzalkonium chloride-preserved travoprost/timolol fixed combination and latanoprost/timolol fixed combination. Ocul Pharmacol Ther. 2011;27:273-280.
54. Kahook MY, Noecker RJ. Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears. Cornea. 2008;27:339-343.
55. Cha SH, Lee JS, Oum BS, Kim CD. Corneal epithelial cellular dysfunction from benzalkonium chloride (BAC) in vitro. Clin Exp Ophthalmol. 2004;32:180-184.
56. Lemp MA, Zimmerman LE. Toxic endothelial degeneration in ocular surface disease treated with topical medications containing benzalkonium chloride. Am J Ophthalmol. 1988; 105:670-673.
57. Berdy GJ, Abelson MB, Smith LM, George MA. Preservative-free artificial tear preparations. Assessment of corneal epithelial toxic effects. Arch Ophthalmol. 1992;110:528-532.
58. Benesova J, Hock M, Butenko O, Prajerova I, Anderova M, Chvatal A. Quantification of astrocyte volume changes during ischemia in situ reveals two populations of astrocytes in the cortex of GFAP/EGFP mice. J Neurosci Res. 2009;87:96-111.
59. Pogue BW, Hasan T. Fluorophore quantitation in tissue-simulating media with confocal detection. IEEE J Selected Topics in Quant Elec. 1996;2:959-964.
60. Cui L, Huxlin KR, Xu L, MacRae S, Knox WH. High-resolution, noninvasive, two-photon fluorescence measurement of molecular concentrations in corneal tissue. Invest Ophthalmol Vis Sci. 2011;52:2556-2564.
61. Spoerl E, Raiskup F, Kampik D, Geerling G. Correlation between UV absorption and riboflavin concentration in different depths of the cornea in CXL. Curr Eye Res. 2010; 35:1040-1041.
62. Kampik D, Ralla B, Keller S, Hirschberg M, Friedl P, Geerling G. Influence of corneal collagen crosslinking with riboflavin and ultraviolet-a irradiation on excimer laser surgery. Invest Ophthalmol Vis Sci. 2010;51:3929-3934.
63. Iseli HP, Popp M, Seiler T, Spoerl E, Mrochen M. Laboratory measurement of the absorption coefficient of riboflavin for ultraviolet light (365 nm). J Refract Surg. 2011;27:195-201.
64. Ammar DA, Noecker RJ, Kahook MY. Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells. Adv Ther. 2010;27:837-845.
65. Means TL, Geroski DH, L'Hernault N, Grossniklaus HE, Kim T, Edelhauser HF. The corneal epithelium after optisol-GS storage. Cornea. 1996;15:599-605.
66. Brasnu E, Brignole-Baudouin F, Riancho L, Warnet JM, Baudouin C. Comparative study on the cytotoxic effects of benzalkonium chloride on the Wong-Kilbourne derivative of Chang conjunctival and IOBA-NHC cell lines. Mol Vis. 2008; 14:394-402.
67. De Saint Jean M, Brignole F, Bringuier AF, Bauchet A, Feldmann G, Baudouin C. Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells. Invest Ophthalmol Vis Sci. 1999;40:619-630.